9-94606867-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000375326.9(FBP1):c.653G>A(p.Arg218Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.94 in 1,613,876 control chromosomes in the GnomAD database, including 713,898 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000375326.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBP1 | NM_000507.4 | c.653G>A | p.Arg218Lys | missense_variant | 5/7 | ENST00000375326.9 | NP_000498.2 | |
FBP1 | NM_001127628.2 | c.653G>A | p.Arg218Lys | missense_variant | 6/8 | NP_001121100.1 | ||
FBP1 | XM_006717005.5 | c.407G>A | p.Arg136Lys | missense_variant | 5/7 | XP_006717068.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBP1 | ENST00000375326.9 | c.653G>A | p.Arg218Lys | missense_variant | 5/7 | 1 | NM_000507.4 | ENSP00000364475.5 |
Frequencies
GnomAD3 genomes AF: 0.960 AC: 146064AN: 152202Hom.: 70103 Cov.: 33
GnomAD3 exomes AF: 0.956 AC: 240380AN: 251358Hom.: 115021 AF XY: 0.955 AC XY: 129666AN XY: 135846
GnomAD4 exome AF: 0.938 AC: 1371406AN: 1461556Hom.: 643734 Cov.: 48 AF XY: 0.939 AC XY: 682622AN XY: 727080
GnomAD4 genome AF: 0.960 AC: 146184AN: 152320Hom.: 70164 Cov.: 33 AF XY: 0.960 AC XY: 71501AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Fructose-biphosphatase deficiency Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at